Plain Language of "At Least One" Does Not Require Two, Despite Disclosures in the Specification to the Contrary
Client Alert | 1 min read | 09.09.08
In Howmedica Osteonics Corp. v. Wright Medical Technology Inc. (No. 07-1363; Sept. 2, 2008), the Federal Circuit vacates a stipulated judgment of noninfringement due to an "incorrect" claim construction by the district court.
A knee prosthesis patent described the replacement of the lower portion of the femur, including one or both of its rounded projections called condyles. A "unicondylar" prosthesis replaces one condyle; a "bicondylar" prothesis replaces both. The district court construed the term "femoral component including at least one condylar element" as requiring that both condyles in a bicondylar prosthesis meet the geometric requirements of the claim.
Because the plain language of the claim requires only one condylar element, the Federal Circuit rejects the district court's claim construction. Further none of Wright's proffered arguments showed that the term should be interpreted other than by its plain language. First, there is no requirement that every claim be limited to encompass all the advantages or purposes disclosed in the specification, which Wright argued could not be achieved by only one condyle meeting the geometric limitations. Second, although every disclosure of a bicondylar knee in the specification showed two condyles meeting the geometric requirements, this single embodiment, without more, is insufficient to limit the claim. Third, a letter between a prosecuting attorney and a patent applicant reporting on the results on an examiner interview is not part of the prosecution history and, moreover, is of "no value" to the construction of the claim. Finally, the testimony of an inventor of the patent, even if to narrow the scope of the claims and thus against the interest of the inventor, is irrelevant on the issue of claim construction.
Contacts
Insights
Client Alert | 4 min read | 11.10.26
D.C. District Court Upholds CMS’s 2020 Organ Procurement Rule
It’s been about a month since the U.S. District Court for the Middle District of Florida upheld the Centers for Medicare and Medicaid’s (CMS) final rule governing organ procurement organizations (OPM). (See our previous Client Alert here.) The U.S. District Court for the District of Columbia followed suit. In contrast to the Florida decision, the D.C. decision was brief and to the point. The rule establishes a competitive model for classifying OPOs under the following three tiers.
Client Alert | 8 min read | 11.10.26
EU Simplifies Rules on Defense Procurement and Transfers of Defense-Related Products
Client Alert | 3 min read | 11.09.26
Client Alert | 4 min read | 11.09.26

